In a couple of months, China’s mammoth ecommerce company Alibaba will become a publicly listed company. Estimates for its value at the time range from $120 billion to $250 billion. That’s quite a range, and investors are itching to know which end it will come closer to. Will it execute a Facebook-like belly flop, and come in at — or below — the low end? Or will it make millions of dollars for first-in investors by coming in near the top end? Well, according to The Financial Times, that figure depends four factors concerning the company’s growth, including sales seasonality, the percentage of each sale the company retains, the company’s presence in mobile purchasing and Chinese consumer spending. If you, or your investing network, have an inside track on knowing about any of these variables, that may be enough to tip the scales in your favor — which will be all you need when Alibaba goes pubic.
Jim Woods has over 20 years of experience in the markets from working as a stockbroker, financial journalist, and money manager. As well as a book author and regular contributor to numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:
Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:
Get free access to "Millionaire Maker" Hilary Kramer's latest report 3 Biotech Breakthroughs To Bank On. Simply tell us where to send it in the box below.
*Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk. We value your privacy. You will not be spammed, ever. Period.